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ABSTRACT 
Objectives:  The purpose of this study is to assess the effectiveness and advantage of endoscopic mono-nostril 
approach to the pituitary tumors. 
Materials and Methods:  We analyzed 70 patients undergoing transsphenoidal mono-nostril excision of pituitary 
tumors from September, 2016 to March, 2018. 
Results:  We operated 70 patients, out of which 51 were males and 19 were females; the age of the patients 
ranged from 15 years to 65 years.In our study, out of 70 patients, 61 (87.1%) patients had excellent results with 
total tumor resection, marked visual improvement, early discharge on the second post-operative day, resuming 
their daily activities within two weeks and recurrence free interval of 1 year. Nine (12.8%) of our patients had a 
partial excision of the tumor, whereby there was improvement of headaches in all of them while visual status 
remained at the pre-operative status. Five (7.1%) of our patients had a post-operative cerebral spinal fluid (CSF) 
rhinorrhea, 4 (5.7%) in total excision group and 1 (1.4%) in partial excision group. These patients of CSF leak 
were retained in hospital and their mean stay in hospital was 12   4. Two cases were re-explored and the nasal 
reconstruction was done via inlay outlay graft using the other nostril, post operatively the CSF leak stopped. Only 
1 patient had a trans-cranial repair of dura for CSF leak. One (1.4%) of our patient expired post operatively. 
Conclusion:  We consider that endoscopic mono-nostril excision of the pituitary tumor is a relatively safer, 
effective, minimally invasive procedure; whereby there is a fast recovery, early discharge and good cosmetic 
results. 
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INTRODUCTION 
The pituitary gland has fascinated clinicians for many 
decades, it was believed to be an organ draining the 
waste products from the brain through nostrils. In 
1930, when the vasopressin and oxytocin was 
discovered to be secreted by pituitary, it was then 
considered as a gland and the pituitary gland become 
“the conductor of the endocrine orchestra1Harvey 
Cushing was the first person pioneering the 
transsphenoidal approach to the pituitary gland.Sir 
Victor Horsley, performed a series of transsphenoidal 
approach in 10 patients from 1904 to 1906, but 
couldn’t get the desire results. The first successful 
approach was made in 1907 by Schloffer. 
 In 1978, Bushe and Halves introduced the use of 
the endoscope in pituitary operation1. However, it was 
not until the mid-1990s that the endoscope gained 
popularity for pituitary operation after 
otolaryngologists started using it for a sinus operation 
with improved visualization and good working space. 
Yaniv and Rappaport described a combined approach 
in which the endoscope was used for the initial 
approach to the sphenoid sinus, followed by 
conversion to the standard transsphenoidal 
microsurgical approach for the tumor resection.2 Jho 
and Carrau later reported the largest series of patients 
who had undergone pure endoscopic endonasal 
transsphenoidal operation.3 
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 Since the introduction of the endoscopic 
transsphenoidal surgery, most surgeons advocate 
either of two techniques; two surgeons (3 or 4 hands) 
technique, or one surgeon (2 hands) technique utilizing 
an endoscope holder.4,9,17 In the binostril 3-hand 
technique, the ENT surgeon does the exposure, then 
holds the endoscope in one nostril (usually the right) 
and the neurosurgeon works with instruments using 
both nostrils. Usually the neurosurgeon holds the 
suction in the non-dominant hand and a dissecting 
instrument in the dominant one. With the mononostril 
2-hand technique, the ENT surgeon may perform the 
nasal phase of the surgery, but then the endoscope 
holder (hydraulic or mechanical) may be used for the 
rest of the operation.5,8 Furthermore, as discussed by 
Edward Laws and John Jane, the main advantage of 
the mono-nostril technique is lesser trauma to the nasal 
mucosa and thus less nasal morbidity such as crusting, 
loss of smell, and synechia.6 However, the main 
disadvantage is small working room, especially for 
invasive and large macro-adenomas. In this situation, 
the degree of freedom that is gained by the operating 
surgeon is crucial for better surgical outcomes. This 
freedom is gained by the elimination of the endoscope 
shaft, usually used for irrigation and holding, from one 
of the surgeons operating corridors. Based on this, we 
wanted to assess our results looking for the efficacy of 
the mono-nostril technique and compare it to the 
literature with respect to outcome and efficacy. 
 In this paper, we present our series of 70 patients 
of sellar pituitary adenomas operated via the 
endoscopic endonasal transsphenoidal approach using 
a single nostril, 2-hand and 4 handed technique. We 
studied the outcomes, besides the complications of our 
operations. 
 
MATERIALS AND METHODS 
Study Design 
Descriptive prospective study. Seventy patients, age 
ranging from 15 to 65 years, from September, 2016 to 
April, 2018 with pituitary tumor underwent 
transsphenoidal mono-nostril approach in our 
department. 
 
Inclusion Criteria 
All cases of pituitary tumor which were sella and 
superacellar. 
 
Exclusion Criteria 
Recurrent tumor and parasellar extension and children 
below 14 years of age. Cases of Radiosurgery were 
excluded similarly these patients who refused consent. 
 
Data Collection 
In all the patients, pre-operative evaluations, including 
MRI of the brain and sellae, CT scan of sellae, para-
nasal sinuses and sphenoid sinuses were performed. 
We classified the pituitary adenomas according to the 
classification of Hardy (Grade 0 to Grade V) were 
assessed by radiological and intra-operative findings. 
Post-operative CT Scans were done after 72 hours, 
while MRIs were obtained after 3 months of surgery. 
 
Table 1:  Hardy Classification. 
 
Grade Size Extension 
No. of 
Patients 
0 < 10 mm Sella normal 20 
  I < 10 mm Sella expanded 25 
II > 10 mm Sella expanded 16 
III > 10 mm Focal destruction   5 
IV > 10 mm Diffuse destruction   4 
V  Distant spread   0 
 
Operative Technique 
We used the mono-nostril approach in all operations. 
The choice of the nostril was done with the help of a 
preoperative 1-mm cut CT scan of the sinuses. If there 
was no septal deviation we tended to use the right 
nostril, as both surgeons were right handed, and it was 
easier to handle the scope with the left hand and work 
with the right hand. Should there be a septal deviation, 
a sub-mucosal resection of the septum (SMR) or 
operating through the other nostril may be preferred. 
In the nasal stage, the middle turbinate is lateralized, 
and as we reach and identify the sphenoid ostium on 
one side, we continue in a sub-mucosal fashion across 
the perpendicular plate of the ethmoid to expose the 
contra-lateral ostium as shown in figure 1. 
 Removing the bone between the two ostia and 
connecting them in one big hole creates a wider 
working space demonstrated in figure 2. The mucosa 
over the entered ostium is either coagulated or used to 
make a flap for better closure, whereas the mucosa on 
the other side is kept intact for better healing of the 
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nose. In the sphenoidal stage as we enter the scope into 
the sphenoid sinus, the scope is handed over to the 
assistant making it a four handed technique, who will 
push it into the upper corner of the nostril. Under some 
circumstances, we can also use 2-handed technique 
 
 
 
Fig. 1: Endoscopic view of the nasal anatomy, showing the 
medial turbinate (M.T) on the left, nasal septum 
(N.S) on the right and sphenoid ostium (S.O) in the 
middle. 
 
 
 
Fig. 2: After entering the ostium and removing the vomer 
bone, sphenoid sinus is entered drilling the floor of 
sinus and exposing the sella turcica. 
with suction in the left hand and the other working 
instrument in the right one. After incising the dura in 
cruciate manner, the tumor bulges by itself and 
adenoma is removed using ring curettes in the corners 
with visualization of an endoscope. After tumor 
removal, and identifying the arachnoid pulsation the 
reconstructive phase is started by applying surgical 
and fixing up with fibrin glue. A fat graft, taken from a 
small abdominal incision, in some cases was tucked in 
and fixed with glue. 
 
Data Analysis 
It was done SPSS Version 20. 
 
RESULTS 
Gender Distribution 
We operated 70 patients, out of which 51 were males 
and 19 were females. 
 
Age Incidence 
The age of the patients ranged from 15 years to 65 
years. 
 
Clinical Outcome with Reference to Excession 
of Tumor 
Group A: Total Excision 
The surgical removal of tumor (Fig. 3 and Table 2 & 
3). A total resection in our study, out of 70 patients, 61 
(87.1%) patients had excellent results with total tumor 
resection, marked visual improvement, early discharge 
on the second post-operative day, resuming their daily 
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Fig. 3: Graphical presentation of results for trans-
sphenoidal mononostril excision of pituitary tumors. 
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Table 2:  Clinical Outcome with Reference to Excision of Tumor. 
 
Group A Headache Improved  Vision Improved 
 Yes No Yes No 
Excision 61 (87.1%) Cases 61 (100%) Nil 61 (100%) Nil 
Group B     
Partial Excision 9 (12.8%) Cases All 9 Cases (100%) Nil Nil All Static 9 Cases (100%) 
 
Table 3:  Visual Improvement. 
 
Extent of Excision 
Vision Improvements Static Vision 
No. % No. % 
Total Excision 61 cases 61 100%   
Partial excision 9 cases   9 100% 
 
activities within two weeks and recurrence free 
interval of 1 year. 
 
Partial Excision 
Nine (12.8%) of our patients had a partial excision of 
the tumor. There was improvement of headaches in all 
of them while visual status remained at the pre-
operative status. There was no case of visual 
deterioration. 
 
Complications 
Table shows the complications. Five (7.1%) of our 
patients had a post-operative cerebral spinal fluid 
(CSF) rhinorrhea, 4 (5.7%) in total excision group and 
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Fig. 4: Pre-Operative and Post-Operative Assessment of 
Visual Status. 
1 (1.4%) in partial excision group. These patients of 
CSF leak were retained in hospital and their mean stay 
at hospital was 12  4. Two cases were re-explored 
and the nasal reconstruction was done via inlay outlay 
graft using the other nostril, post operatively the CSF 
leak stopped. Only 1 patient had a trans-cranial repair 
of dura for CSF leak. One (1.4%) of our patient 
expired post operatively. 
 
DISCUSSION 
Our results are comparable to most endoscopic and 
microscopic series reported in the literature. We have 
achieved a gross total resection of 87% for non-
invasive macro-adenomas overall, with a stable 
residual in 13%. Among those, the non-secreting 
adenomas had a 78% gross total resection rate, with 
22% having a small stable residual at their last follow-
up (near total removal). The invasive non-secreting 
adenomas on the other hand had an initial 87% near 
total resection. Long-term surgical stability at last 
follow up was thus achieved in patients with invasive 
nonfunctioning adenomas. Of note is that most of the 
residuals or recurrences requiring another operation or 
radiation therapy occurred in the invasive adenoma 
group. 
 As for patients with preoperative visual field 
disturbances, complete recovery of vision was seen in 
40%–50% of the cases and improvement in 39%–51% 
of the cases in two large endoscopic series.7,12,13,15 In 
our series, we had 60% complete recovery of vision 
and improvement was seen in another 30% of patients. 
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One patient who had presented with a third nerve palsy 
had near total recovery after operation.One common 
complication is transient diabetes insipidus. Permanent 
diabetes insipidus is much less common and is seen in 
around 1% of the cases.8,15 Postoperative CSF leak rate 
ranges around 2%–4%, and in the 200 patients 
reported by Dehdashti et al, it was 3.5%.7,8,16 Only 2% 
of our patients had persistent diabetes insipidus and 
one had s postoperative CSF leak. 
 Hospital stay is relatively short in most endoscopic 
series, and in one retrospective study, Neal et al. 
showed a significant decrease in hospital stay (3.4 
days) and operation time (4.41 hours) using the 
endoscopic approach9. In our series, the hospital stay 
ranged from 2 to 5 days with an average of 2.8 days. 
The operative time ranged around 2.2–4 hours with an 
average of 2.8 hours. 
 The endoscopic trans-nasal approach offers 
excellent results when it comes to removal of pituitary 
tumors, with less nasal complication rates when 
compared to the microscopic sub-labial trans-
sphenoidal approach.10,16 However, there is 
controversy as to whether the bi-nostril or mono-
nostril endoscopic approach is superior. Some 
neurosurgeons prefer the mono-nostril approach, 
whereas the otolaryngologists prefer the bi-nostril 
approach.4,11 Far from being a rule, however, this has 
created controversy over the preferred endoscopic 
approach for pituitary lesions. 
 As for the bi-nostril approach, the ostia are 
separately and bilaterally identified and the mucosa 
can then be coagulated or turned as a flap. The scope 
is held, usually by the ENT (Ear, Nose, & Throat) 
surgeon or by scope holder, in one nostril usually the 
right and the neurosurgeon works through both nostrils 
with his two hands. The major advantage in this 
approach is the dynamic process achieved with both 
surgeons working together at the same time. The space 
afforded for surgical instruments is also wider, with 
easier manoeuvring.The major disadvantage is mucosa 
disruption on both sides of the sphenoid ostium, which 
may lead to more nasal crusting and discomfort. 
 We have described earlier our usual single nostril 
approach, where after lateralization of the middle 
turbinate, localization of one sphenoid ostium, and 
exposure of the ethmoid plate, the contra-lateral 
ostium is performed. The central bone removal affords 
an acceptable wide working space. It is generally felt 
that the preservation of the contra-lateral mucosa is 
important for proper healing of the nose.As pituitary 
tumors are usually soft and easily removed with 
pituitary curettes and suction, the authors believe that 
the space provided by the single nostril approach is 
enough, though sometimes a bit crowded, to perform 
the procedure with high success rate. The authors, 
further, remove the endoscope holder towards the end 
of tumor resection, and inspect the surgical field in a 
dynamic fashion through the same nostril allowing 
further removal of possible missed tumor. The 
approach is minimally invasive and the nose heals 
quickly, especially with an intact mucosa on the 
contra-lateral sphenoid ostium and proper 
medialization of the middle turbinate at the end of the 
procedure. Our results, further, have been comparable 
to most endoscopic series, with a very low 
complication rate. 
 
LIMITATION OF STUDY 
Limitations to the mono-nostril approach may be a 
crowded narrow nasal cavity, a harder tumor with 
invasive appearance or significant supra-sellar 
extension, and lesions other than pituitary adenomas. 
The mono-nostril surgery may then be simply turned 
into a bi-nostril, wider and more dynamic approach to 
allow for better dissection of such larger, harder, and 
more extensive tumors. 
 
CONCLUSION 
In conclusion, we have reviewed our experience with 
the mono-nostril endoscopic approach for pituitary 
tumors in 70 patients. We have shown comparable 
results to the bi-nostril technique, mostly reported in 
endoscopic series, in pituitary adenomas, as the 
endoscope allows inspection of the hidden corners and 
supra-sellar region, allowing for a more nearly 
complete resection. The recurrence and complication 
rates were quite low, mostly limited to recurrent or 
invasive adenomas. We feel that the mono-nostril 
approach is simple, less traumatic, and sufficient for 
pituitary adenoma surgery to achieve a good outcome. 
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